Blennow K - Search Results

1

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.

Magdalinou NK, Noyce AJ, Pinto R, Lindstrom E, Holmén-Larsson J, Holtta M, Blennow K, Morris HR, Skillbäck T, Warner TT, Lees AJ, Pike I, Ward M, Zetterberg H, Gobom J. Magdalinou NK, et al. Among authors: blennow k. Parkinsonism Relat Disord. 2017 Apr;37:65-71. doi: 10.1016/j.parkreldis.2017.01.016. Epub 2017 Jan 31. Parkinsonism Relat Disord. 2017. PMID: 28214264

2

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L. Blennow K, et al. Int Psychogeriatr. 1994 Spring;6(1):13-22; discussion 59-60. doi: 10.1017/s1041610294001584. Int Psychogeriatr. 1994. PMID: 8054491

3

A new procedure for detecting brain-specific proteins in cerebrospinal fluid.

Davidsson P, Ekman R, Blennow K. Davidsson P, et al. Among authors: blennow k. J Neural Transm (Vienna). 1997;104(6-7):711-20. doi: 10.1007/BF01291888. J Neural Transm (Vienna). 1997. PMID: 9444570

4

Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype.

Wallin A, Blennow K, Rosengren L. Wallin A, et al. Among authors: blennow k. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S102-5. Alzheimer Dis Assoc Disord. 1999. PMID: 10609688 Review.

5

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K. Hesse C, et al. Among authors: blennow k. Neurosci Lett. 2001 Jan 19;297(3):187-90. doi: 10.1016/s0304-3940(00)01697-9. Neurosci Lett. 2001. PMID: 11137759 Clinical Trial.

6

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients.

Davidsson P, Westman-Brinkmalm A, Nilsson CL, Lindbjer M, Paulson L, Andreasen N, Sjögren M, Blennow K. Davidsson P, et al. Among authors: blennow k. Neuroreport. 2002 Apr 16;13(5):611-5. doi: 10.1097/00001756-200204160-00015. Neuroreport. 2002. PMID: 11973456

7

The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease.

Zetterberg H, Nexö E, Regland B, Minthon L, Boson R, Palmér M, Rymo L, Blennow K. Zetterberg H, et al. Among authors: blennow k. Clin Chem. 2003 Jul;49(7):1195-8. doi: 10.1373/49.7.1195. Clin Chem. 2003. PMID: 12816923 No abstract available.

8

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease.

Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P. Puchades M, et al. Among authors: blennow k. Brain Res Mol Brain Res. 2003 Oct 21;118(1-2):140-6. doi: 10.1016/j.molbrainres.2003.08.005. Brain Res Mol Brain Res. 2003. PMID: 14559363

9

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

Zetterberg H, Wahlund LO, Blennow K. Zetterberg H, et al. Among authors: blennow k. Neurosci Lett. 2003 Nov 27;352(1):67-9. doi: 10.1016/j.neulet.2003.08.011. Neurosci Lett. 2003. PMID: 14615052

10

Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease.

Johansson A, Katzov H, Zetterberg H, Feuk L, Johansson B, Bogdanovic N, Andreasen N, Lenhard B, Brookes AJ, Pedersen NL, Blennow K, Prince JA. Johansson A, et al. Among authors: blennow k. Hum Genet. 2004 May;114(6):581-7. doi: 10.1007/s00439-004-1107-9. Epub 2004 Mar 18. Hum Genet. 2004. PMID: 15034781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,194 results

Search Page

Filters